Product Information
HYDROXYZINE PAM 100 MG CAP is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.4446 per EA under NDC 00555032402. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Jun 15, 1984.
The High Outlier badge above means this manufacturer's average price in the Hydroxyzine Pamoate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
100 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00555032402
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
HYDROXYZINE PAMOATEApproval Type
Generic (ANDA)
FDA Application
ANDA088488FDA Approved
6/15/1984
On Market Since
7/1/1984
Pharmacological Classes
Price Statistics
The NADAC for HYDROXYZINE PAM 100 MG CAP has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 78.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4446 per EA |
|---|---|
| All-time high | $0.5397 (Sep 14, 2016) |
| All-time low | $0.2375 (Apr 23, 2014) |
| 52-week high | $0.4471 |
| 52-week low | $0.4057 |
| Median price | $0.4224 |
| Average price | $0.4166 |
| Largest weekly change | +59.9% (Jun 18, 2014) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Hydroxyzine Pamoate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of HYDROXYZINE PAM 100 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for HYDROXYZINE PAM 100 MG CAP, manufactured by Teva Pharmaceuticals USA Inc., is $0.4446 per EA (NDC 00555032402), effective Aug 19, 2026.
How has the price of HYDROXYZINE PAM 100 MG CAP changed over time?
Over the history we have for it, the NADAC for HYDROXYZINE PAM 100 MG CAP has risen 78.3%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for HYDROXYZINE PAM 100 MG CAP?
Since Nov 28, 2013, the NADAC for HYDROXYZINE PAM 100 MG CAP has ranged from a low of $0.2375 (Apr 23, 2014) to a high of $0.5397 (Sep 14, 2016), with a median of $0.4224 per EA.
Are there cheaper alternatives to HYDROXYZINE PAM 100 MG CAP?
No other NADAC-published product currently shares the active ingredient and strength of HYDROXYZINE PAM 100 MG CAP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures HYDROXYZINE PAM 100 MG CAP?
HYDROXYZINE PAM 100 MG CAP (NDC 00555032402) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.